Skip to main content

This job has expired

You will need to login before you can apply for a job.

Director, Outsourcing and Alliance Management

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Mar 11, 2023

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How you will Achieve More with Intellia:

​​​As the Director CRO Outsourcing and Alliance Management, you will be a member of the Development Operations Leadership team and report into the Vice President, Development Operations. This is a key member of the Development Operations team and will partner closely with the Strategic Sourcing, Clinical Operations, Program Therapeutic Leads, R&D Medicine, and GCP Quality to lead the development and execution of Clinical Research Organization (CRO) and other key clinical vendor management structure for gene editing therapies. In addition, this leader will develop and foster preferred CRO and key vendor partnerships, lead governance forums, and is responsible for alliance management to drive strategic and operational efficiencies. This team member will ensure CRO and vendor activities meet Intellia and quality and global compliance standards​

About You:

​​You are a subject matter expert (SME) and key clinical development team member who would embrace the challenge to create an innovative national and global outsourced development partnering approach to Intellia’s CRISPR/cas9 programs.

  • ​Minimum of a completed Bachelor's degree

  • ​10+ years' experience in strategic sourcing and alliance management experience in either a pharmaceutical/biotech company or CRO

  • ​Financial modeling and negotiation experiences

  • ​Thorough understanding of the global drug development process and project management skillset

  • ​Ability to identify, develop and help lead alternative operational approaches within the preferred partnerships, affording greater CRO/vendor accountability and responsibility

  • ​Solid organizational and communication skills, with the ability to successfully interface with the CRO and vendor executives, alliance manager and study teams

  • ​Ability to understand and respond to multiple external and stakeholder needs, manage and handle conflict constructively required

  • ​Ability to inform senior level leadership to all aspects of operational management, relationship management, and the preferred partner alliances

  • ​Ability to manage teams/individuals and provide career development and mentor staff

You will be responsible for:

  • ​Maintain an appropriate level of knowledge and understanding regarding project issues with the ability to "drill down" to detail as needed

  • ​In partnership with Strategic Sourcing, develop and implement analytical methods and metrics to improve CRO and vendor decision making, measure value, and enable a more strategic view of the outsourcing portfolio

  • ​Develop and implement processes for vendor identification, selection, and qualification while working colleagues across functions, including Clinical Operations, Finance, Strategic Sourcing, Legal, Quality Assurance, and other applicable functions.

  • ​Through alliance management, develop Key Performance Indicators to measure CRO performance and drive clinical development goals, operational efficiency, quality and compliance

  • ​Ensure KPIs and metrics from strategic CRO and vendor partnerships are appropriately quantifying the overall relationship and program health, ensure ability to quantify improvements and/or declines in: productivity, efficiencies, costs, and quality

  • ​Through alliance management, oversee all CRO and key vendor service lines and drive resolution of issues

  • ​Develop of tracking accrual processes with vendors to align with cross-functional requirements

  • ​Influence service providers to ensure outstanding partnering approaches leading to satisfaction across the Intellia stakeholder team

  • ​Ensure that clinical development and clinical operations project plans and timelines are thoroughly developed and vetted with the Intellia teams and CRO/vendor teams to meet/exceed the program objectives

  • ​Partner with CRO and key vendors to ensure line of site related to high-level program needs for resources and methods to ensure ability to take action when required to meet targets

  • ​Work effectively with Intellia teams, CRO alliance management, CRO/vendor teams to identify potential and actual issues and efficient issue resolution

  • ​Ensure continued success of strategic partnerships

  • ​Establish and lead governance across clinical supplier relationships (CROs and other key vendors) from inception to implementation, manage governance plan, and provide guidance to key Intellia stakeholders

  • ​Serve as an escalation point for key CRO and vendor relationships

  • ​Support purchase order processing

  • ​In partnership with Development Operational Excellence team members, establishes Intellia framework for applying industry best practices, utilizing external sources such as benchmarking, data, and processes to continually drive CRO and vendor improvements linked to an overall operational and program strategy

  • ​Lead the functional evaluation of CRO or key vendor processes or process improvement opportunities

  • ​Stays abreast of industry trends regarding the new specialty outsourcing services /solutions

  • ​Expertise regarding CROs, specialty vendors, including their leadership, organizational structure, business development strategies, financial health, operating strengths

  • ​In partnership with Development Operational Excellence, identify innovative new processes and tools to enhance clinical trial designs and execution

  • ​Provides leadership in a highly matrixed environment, who will mentor Clinical Operations professionals on CRO and vendor oversight and partnering approaches​

Meet your future team:

​​The Clinical Development Team at Intellia is here because we believe genome editing has incredible potential to treat and cure life-threatening and fatal diseases, and we believe the Intellia has the right people, strategy, and culture to do it well.  It is made up of one or more people in functions related to clinical research, including but not limited to biometrics, clinical operations, development operations, clinical pharmacology, R&D Medicine, medical writing, project leadership, medical affairs, and regulatory affairs.

​The Clinical Operations and Development Operations team is led by our Vice President, Development Operations, a pharmacist with a Masters degree in Business with over 25 years of experience in biotech drug development. Other senior team members have 10 or more years of similar experience, including many with prior direct experience in nucleic acid therapeutics and cell therapy.​

Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert